National Trends in Aspirin Use and Expenditures in the United States: Analysis of The Medical Expenditure Panel Survey 2000–2021
Abstract Introduction Since its invention in 1897, aspirin (ASA) has been the most widely used and cost-effective antiplatelet agent to prevent and treat atherosclerotic cardiovascular disease (ASCVD). We aimed to study the trends and expenditures associated with ASA use in the USA. Methods We condu...
Saved in:
| Main Authors: | Harshith Thyagaturu, Shafaqat Ali, Karthik Seetharam, Prakash Upreti, Akshith Doddi, Lalitsiri Atti, Nicholas Roma, Jordan L. Lacoste, Aakash Angirekula, Joseph Salami, Khurram Nasir, Sudarshan Balla |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2024-10-01
|
| Series: | Cardiology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40119-024-00385-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of dual antithrombotic strategy (low-dose rivaroxaban + aspirin) in therapy: Joint consensus document of the Hungarian Society of Angiology and Vascular Surgery (MAÉT), the Hungarian Society of Cardiology (MKT) and the Hungarian Stroke Society (MST)
by: Zoltán Járai, et al.
Published: (2025-02-01) -
ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE
by: M. G. Bubnova
Published: (2010-08-01) -
Aspirin in the Modern Era of Cardiovascular Disease Prevention
by: Ella Murphy, et al.
Published: (2021-09-01) -
Global research trends and hotspots in aspirin studies (2014–2024): a bibliometric perspective
by: Ning Sun, et al.
Published: (2025-05-01) -
Administration of aspirin and risk of pancreatic ductal adenocarcinoma
by: Arooba Noor Abbasi, et al.
Published: (2024-12-01)